New England Journal of Medicine , 389 (24), 22212232
From a research perspective, the comparison question is not just Which is stronger? It is What does the added glucagon-receptor component change? What the Retatrutide Literature Suggests Retatrutides published phase 2 obesity results showed substantial dose-related body-weight reductions at 24 and 48 weeks
Presented at Digestive Disease Week (DDW) 2025, the study demonstrates how Phenomixs proprietary machine learning algorithms can predict which individuals are more likely to experience side effectsparticularly nauseawhen undergoing GLP-1 receptor agonist therapy
This has led to suggestions that excessive folic acid supplementation could, under certain circumstances, induce a functional folate deficiency
Contact our practice in Victoria, TX, at (361) 576-9100 to schedule a consultation.